NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,114 filers reported holding NOVARTIS A G in Q3 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,391 | +112.0% | 210 | +110.0% | 0.01% | +150.0% |
| Q2 2023 | $10,091 | +9.7% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $9,200 | +1.4% | 100 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $9,072 | -24.4% | 100 | -37.5% | 0.00% | -33.3% |
| Q3 2022 | $12,000 | +50.0% | 160 | +60.0% | 0.00% | +50.0% |
| Q2 2022 | $8,000 | -11.1% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $9,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $9,000 | -85.0% | 100 | -86.3% | 0.00% | -86.7% |
| Q3 2021 | $60,000 | -10.4% | 732 | 0.0% | 0.02% | -6.2% |
| Q2 2021 | $67,000 | +6.3% | 732 | 0.0% | 0.02% | 0.0% |
| Q1 2021 | $63,000 | -8.7% | 732 | 0.0% | 0.02% | -20.0% |
| Q4 2020 | $69,000 | +666.7% | 732 | +632.0% | 0.02% | +566.7% |
| Q3 2020 | $9,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $9,000 | -35.7% | 100 | -39.0% | 0.00% | -40.0% |
| Q1 2020 | $14,000 | +55.6% | 164 | +64.0% | 0.01% | +150.0% |
| Q4 2019 | $9,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXENCIAL WEALTH ADVISORS, LLC | 188,514 | $13,713,000 | 5.95% |
| PRENTISS SMITH & CO INC | 136,441 | $10,133,000 | 5.74% |
| MANAGED ASSET PORTFOLIOS, LLC | 204,985 | $15,225,000 | 5.46% |
| Osher Van de Voorde Investment Management | 108,725 | $8,075,000 | 4.40% |
| BROWN BROTHERS HARRIMAN & CO | 10,796,684 | $801,870,000 | 4.35% |
| SECTORAL ASSET MANAGEMENT INC | 472,296 | $35,077,000 | 4.10% |
| PROFESSIONAL ADVISORY SERVICES INC | 235,347 | $17,479,000 | 3.87% |
| Elefante Mark B | 5,619 | $417,000 | 3.78% |
| SPHERA FUNDS MANAGEMENT LTD. | 255,000 | $18,959,000 | 3.71% |
| CGOV Asset Management | 997,161 | $98,662,000 | 3.61% |